22 (Bloomberg) -- Vivus Inc.'s weight-loss pill Qnexa won the backing of a US advisory panel as the company seeks to gain approval for the first new obesity drug in 13 years. The shares doubled in late trading. Advisers to the Food and Drug ... See all stories on this topic »
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment